Connexin 43 Gene Therapy Delivered by Polymer-Modified Salmonella in Murine Tumor Models
Open Access
Abstract
The use of preferentially tumor-targeting bacteria as vectors is one of the most innovative approaches for the treatment of cancer. This method is based on the observation that some obligate or facultative anaerobic bacteria are capable of selectively multiplying in tumors and inhibiting their growth. Previously, we found that the tumor-targeting efficiency of Salmonella could be modulated by modifying the immune response to these bacteria by coating them with poly(allylamine hydrochloride) (PAH), and these organisms are designated PAH-S.C. (S. choleraesuis). PAH can provide a useful platform for the chemical modification of Salmonella, perhaps by allowing a therapeutic gene to bind to tumor-targeting Salmonella. This study aimed to investigate the benefits of the use of PAH-S.C. for gene delivery. To evaluate this modulation, the invasion activity and gene transfer of DNA-PAH-S.C. were measured in vitro and in vivo. Treatment with PAH-S.C. carrying a tumor suppressor gene (connexin 43) resulted in inhibition of tumor growth, which suggested that tumor-targeted gene therapy using PAH-S.C. carrying a therapeutic gene could exert antitumor activities. This technique represents a promising strategy for the treatment of tumors.Keywords
This publication has 18 references indexed in Scilit:
- Salmonella enhance chemosensitivity in tumor through connexin 43 upregulationInternational Journal of Cancer, 2013
- Tracking of mouse breast cancer stem-like cells with SalmonellaExperimental Biology and Medicine, 2012
- Monotherapy with a Tumor-Targeting Mutant of S. typhimurium Inhibits Liver Metastasis in a Mouse Model of Pancreatic CancerJournal of Surgical Research, 2010
- Vessel destruction by tumor-targetingSalmonella typhimuriumA1-R is enhanced by high tumor vascularityCell Cycle, 2010
- Tissue-specific gene delivery via nanoparticle coatingBiomaterials, 2010
- Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimuriumCell Proliferation, 2009
- Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain ofSalmonella typhymuriumCell Cycle, 2009
- Targeted Therapy with aSalmonella TyphimuriumLeucine-Arginine Auxotroph Cures Orthotopic Human Breast Tumors in Nude MiceCancer Research, 2006
- Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimuriumProceedings of the National Academy of Sciences, 2005
- Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor modelsThe Journal of Gene Medicine, 2004